Health
Surprising discovery reveals new target for aggressive lung adenocarcinoma – News-Medical.Net
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer. These drugs inhibit cancer cells by thwarting the molecular changes that drive them to grow while largely sparing healthy tissues. But for the other two-thirds of people with this type of cancer, there are fewer treatment options.
A team from Memorial Sloan Kettering is reporting new findings about a particularly aggressive subset of lung adenocarcinomas that are…
-
General15 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News21 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
General20 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business23 hours agoBell Potter names the best ASX shares to buy in October